Abalos Therapeutics is an Essen, Germany-based developer of novel immuno-virotherapies against cancer.
Abalos Therapeutics has raised €43M across 1 funding round from 8 investors, most recently a Series A round in Oct 2021. Based in Essen, Germany; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-10-12 | Series A |
| €43M |
| Boehringer Ingelheim,Coparion,Gründerfonds Ruhr,High-Tech Gründerfonds (HTGF),Hx Bio Ventures,NRW.BANK+2 more |
| View deal → |
